Showing results (41-50 of 124) with videos related to

Sort By:
Pageof 13
Biorxiv : the Preprint Server for Biology|November 26, 2025
Spatial Partitioning of Core Glycolysis Enables Tissue-Specific Metabolic Programs In VivoIan J Gonzalez, Aaron D Wolfe, Benjamin Clark, et al.
Muscle & Nerve|June 16, 2011
An interactive voice response diary for patients with non-dystrophic myotoniaJeffrey M Statland, Yunxia Wang, Rachel Richesson, et al.
The Journal of Cell Biology|September 10, 2014
Structural analysis and modeling reveals new mechanisms governing ESCRT-III spiral filament assemblyQing-Tao Shen, Amber L Schuh, Yuqing Zheng, et al.
Neurology|November 16, 2012
New immunohistochemical method for improved myotonia and chloride channel mutation diagnosticsOlayinka Raheem, Sini Penttilä, Tiina Suominen, et al.
Heart (British Cardiac Society)|February 4, 2016
Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillationZiad Hijazi, Julia Aulin, Ulrika Andersson, et al.
Brain : a Journal of Neurology|February 13, 2014
Nerve growth factor metabolic dysfunction in Down's syndrome brainsM Florencia Iulita, Sonia Do Carmo, Alison K Ower, et al.
European Heart Journal|August 31, 2012
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trialStefan H Hohnloser, Ziad Hijazi, Laine Thomas, et al.
Stroke|November 2, 2017
Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or WarfarinDragos Vinereanu, Renato D Lopes, Hillary Mulder, et al.
The American Journal of Medicine|November 11, 2017
Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE TrialMeena P Rao, Dragos Vinereanu, Daniel M Wojdyla, et al.
Research Square|June 30, 2025
DNA-guided CRISPR/Cas12 for RNA targetingPiyush Jain, Carlos Orosco, Santosh Rananaware, et al.
Pageof 13